Our partners

ADAMA 2 is being implemented in Benin, Mauritania and Togo as part of the initiative to reinvest 20% of the profits from GlaxoSmithKline (GSK). 
Although the project focuses on HRH, it also involves other stakeholders: indeed, all health-related actors will have their role to play: